LEO, Eliana Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.483
AS - Asia 9.351
EU - Europa 8.598
SA - Sud America 1.361
Continente sconosciuto - Info sul continente non disponibili 324
AF - Africa 208
OC - Oceania 54
Totale 40.379
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.005
SG - Singapore 2.698
GB - Regno Unito 2.608
CN - Cina 2.552
IT - Italia 2.134
VN - Vietnam 1.071
HK - Hong Kong 1.070
BR - Brasile 1.059
SE - Svezia 1.040
DE - Germania 638
BD - Bangladesh 411
FR - Francia 379
UA - Ucraina 363
FI - Finlandia 360
RU - Federazione Russa 353
KR - Corea 308
TR - Turchia 278
IN - India 270
CA - Canada 249
BG - Bulgaria 151
AR - Argentina 115
NL - Olanda 110
ID - Indonesia 102
JP - Giappone 93
MX - Messico 93
BE - Belgio 77
IQ - Iraq 70
ZA - Sudafrica 62
PL - Polonia 56
ES - Italia 52
PK - Pakistan 47
AE - Emirati Arabi Uniti 46
IR - Iran 46
CO - Colombia 43
IE - Irlanda 43
EC - Ecuador 42
AU - Australia 39
PH - Filippine 39
LT - Lituania 36
CL - Cile 34
MA - Marocco 32
RO - Romania 28
TW - Taiwan 27
MY - Malesia 26
CH - Svizzera 24
CZ - Repubblica Ceca 24
JM - Giamaica 24
KE - Kenya 23
UZ - Uzbekistan 23
EG - Egitto 22
VE - Venezuela 22
TH - Thailandia 21
PY - Paraguay 19
TN - Tunisia 19
NP - Nepal 18
AZ - Azerbaigian 17
CR - Costa Rica 17
IL - Israele 17
JO - Giordania 17
PT - Portogallo 16
SA - Arabia Saudita 16
AT - Austria 14
NZ - Nuova Zelanda 14
PA - Panama 14
DZ - Algeria 13
PE - Perù 13
GR - Grecia 12
TT - Trinidad e Tobago 12
EU - Europa 10
GT - Guatemala 10
KZ - Kazakistan 10
PR - Porto Rico 10
RS - Serbia 10
DK - Danimarca 9
EE - Estonia 9
HN - Honduras 9
HU - Ungheria 9
SV - El Salvador 9
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
LK - Sri Lanka 7
PS - Palestinian Territory 7
BB - Barbados 6
BY - Bielorussia 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
SC - Seychelles 6
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
GE - Georgia 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
GD - Grenada 4
HR - Croazia 4
KW - Kuwait 4
MN - Mongolia 4
Totale 40.004
Salva come PNG Salva come JPEG
Città #
Ashburn 2.466
Southend 1.754
Santa Clara 1.752
Singapore 1.741
Fairfield 1.243
Chandler 1.067
Hong Kong 1.038
San Jose 950
Woodbridge 944
Hefei 798
Jacksonville 711
Council Bluffs 705
Houston 694
Dearborn 573
Nyköping 523
Ann Arbor 521
Wilmington 507
Beijing 496
Seattle 471
Cambridge 430
Los Angeles 388
Chicago 376
London 371
Ho Chi Minh City 344
Modena 284
Hanoi 271
Seoul 269
The Dalles 254
Helsinki 225
Milan 221
New York 221
Izmir 152
Princeton 149
Sofia 141
Lauterbourg 127
Eugene 126
Dallas 125
Salt Lake City 123
Buffalo 121
San Diego 121
Columbus 110
Moscow 109
São Paulo 100
Bremen 94
Rome 94
Shanghai 86
Redwood City 73
Frankfurt am Main 70
Tampa 66
Tokyo 65
Da Nang 61
Fremont 61
Orem 61
Munich 59
Phoenix 58
Bologna 56
Brussels 55
Toronto 55
Atlanta 54
Des Moines 51
Naples 48
Boardman 47
Denver 47
Elk Grove Village 46
Jakarta 45
Warsaw 43
Montreal 41
Ottawa 38
San Francisco 38
Washington 37
Dublin 36
Guangzhou 35
Mexico City 34
Rio de Janeiro 33
Haiphong 32
Mumbai 32
Amsterdam 31
Brooklyn 31
Chennai 31
Falls Church 31
Johannesburg 31
Lancaster 31
Nanjing 29
Belo Horizonte 28
Miami 27
Detroit 26
Formigine 25
Kent 25
Miano 25
New Delhi 25
Baghdad 24
Parma 24
Newark 23
Porto Alegre 23
Dhaka 22
Kunming 22
San Mateo 22
Boston 21
Charlotte 20
Napoli 20
Totale 26.480
Salva come PNG Salva come JPEG
Nome #
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 483
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 477
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 448
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 426
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 423
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 415
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 405
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 401
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 393
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 392
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 389
Bead coating process via an excess of crosslinking agent 382
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 378
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 378
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector 372
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 372
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 369
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 363
Chitosan-alginate microparticles as a protein carrier 359
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 356
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 355
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 354
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 350
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 350
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 349
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 348
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 341
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 340
Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier 336
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 335
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 334
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 328
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 326
In vivo detection of lipid-based nano- and microparticles in the outermost human stratum corneum by EDX analysis 324
Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles 321
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 317
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 317
Vettori particellari per il rilascio sito-specifico di farmaci nel tratto gastro-intestinale 314
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 312
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 312
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 309
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 306
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation 304
Drug delivery strategies of Geraniol via nose-to-brain for the treatment of neuronal disorders 304
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. 303
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 302
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 302
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form 301
Protein immobilization in crosslinked alginate microparticles 298
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 296
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 294
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method 294
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 291
Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates 289
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 287
Cell internalization study of hybrid chitosan-heparin-PLGA nanocarriers on Caco-2 cells 286
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 284
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 280
Preparation and characterization of biodegradable nanoparticles containing a lipophilic drug in water-soluble or insoluble form 278
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 275
Cationic solid lipid nanoparticles containing Protamine as transfection vector on neuroblastoma cell line 273
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 273
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 272
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 272
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 271
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 270
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 270
Formulazione per veicolare principi attivi lipofili 270
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates 269
In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time 267
Oral tolerance elicited in mice by b-lactoglobulin entrapped in biodegradable microspheres. 266
Modified PLGA Nanoparticles as drug carriers for CNS delivery 263
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 263
A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres 260
PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated 258
Caratterizzazione chimico-fisica di membrane e feltri di collagene 258
Formulazione e caratterizzazione di nanoparticelle polimeriche per la somministrazione orale di eparina 254
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 253
In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin 251
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 251
Surface drug removal from ibuprofen-loaded PLA microspheres 251
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 250
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 248
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 247
Studio reologico del complesso alginato/chitosano/albumina per la preparazione di microsfere 246
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 238
The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids 237
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 235
Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight 234
Caratterizzazione chimico-fisica e studi di stabilità di sistemi lipidici per il transfer genico 234
Veicolazione intracellualre di DNA plasmidico mediante solid lipid nanoparticles (SLN) cationiche 233
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 232
Sistemi lipidici per il transfer genico: sintesi di nuove molecole per la progettazione di vettori sintetici efficaci 230
In vitro behaviour of multicomposite cationic SLN as new platform for pDNA delivery 227
Studio della fotodegradazione di un complesso PABA/alginato per la formulazione di filtri solari 227
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 223
Formulazione per veicolare principi attivi lipofili 222
Development of new formulations of cationic solid lipid nanoparticles (SLNs) for the drug delivery to the brain 221
Characterization of cationic SLN/protamine complex as a non-viral transfer vector 220
Ovuli vaginali a rilascio prolungato come inquinanti in pap-test 219
Totale 30.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.985 0 0 0 158 86 174 125 134 314 196 510 288
2022/20232.985 464 350 212 326 337 419 56 243 332 48 113 85
2023/20241.624 77 117 129 161 340 176 161 160 46 38 78 141
2024/20256.582 272 71 187 432 1.203 796 543 499 670 243 748 918
2025/202612.085 780 504 949 1.330 1.828 809 1.491 676 1.297 1.218 655 548
2026/20273.802 363 974 1.349 1.116 0 0 0 0 0 0 0 0
Totale 40.379